找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Acute Myeloid Leukemia; Christoph R?llig,Gert J. Ossenkoppele Book 2021 Springer Nature Switzerland AG 2021 Acute Myeloid Leukemia.Genomic

[復(fù)制鏈接]
樓主: Capricious
11#
發(fā)表于 2025-3-23 13:10:29 | 只看該作者
12#
發(fā)表于 2025-3-23 14:57:05 | 只看該作者
13#
發(fā)表于 2025-3-23 20:03:05 | 只看該作者
14#
發(fā)表于 2025-3-23 22:21:55 | 只看該作者
15#
發(fā)表于 2025-3-24 05:34:51 | 只看該作者
Book 2021 treatment of acute promyelocytic leukemia, current practice of allogeneic stem cell transplantation, and special clinical situations. Finally, promising approaches in drug development, current standards and challenges in assessment of measurable residual disease, immune approaches, and ideas for in
16#
發(fā)表于 2025-3-24 08:19:54 | 只看該作者
Fuels for High-Performance Flight, inhibitors (e.g., etoposide, doxorubicin), and other drugs (e.g., azathioprine) are described to be associated with the development of therapy-related AML (t-AML). Furthermore, about 5–15% of adults and 4–13% of pediatric patients with MDS or AML carry germline pathogenic variants in cancer suscept
17#
發(fā)表于 2025-3-24 12:24:56 | 只看該作者
18#
發(fā)表于 2025-3-24 16:55:17 | 只看該作者
19#
發(fā)表于 2025-3-24 21:04:31 | 只看該作者
Understanding the Basics of Aviation Noise,cytogenetic subgroups and molecular markers such as ., and ., also the screening for ., and . mutations is now recommended. In the future, a better understanding of the clonal evolution leading to malignant transformation and selection of resistant leukemia clones will not only be crucial for refine
20#
發(fā)表于 2025-3-24 23:47:05 | 只看該作者
The Unlawful Interference Conventions, therapies of varying intensity and duration have become available to choose the ideal compromise between organ toxicity and reduction of the risk of relapse in most patients up to the age of about 70 with a good performance status. Inclusion of haploidentical donors and the use of more sensitive te
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 11:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
荔波县| 南平市| 申扎县| 克东县| 金平| 波密县| 龙山县| 屏山县| 修水县| 花莲县| 靖宇县| 台中市| 磴口县| 沂南县| 岑溪市| 宜君县| 江西省| 海阳市| 应城市| 宜都市| 修武县| 重庆市| 和顺县| 安溪县| 鞍山市| 新乐市| 临江市| 姜堰市| 浙江省| 浪卡子县| 南木林县| 德江县| 商都县| 渝北区| 侯马市| 延安市| 达孜县| 砀山县| 马公市| 天等县| 孟州市|